The AJMC® COPD compendium is a comprehensive resource for clinical news and expert insights for chronic obstructive pulmonary disease.
April 26th 2024
Vitamin D supplementation may decrease in-hospital and intensive care unit (ICU) mortality in patients with chronic obstructive pulmonary disease (COPD), a study found.
Perspectives on Emerging Data for the Use of Immunotherapy in the Treatment of Early-Stage Non-Small Cell Lung Cancer
1.5 Credits / Oncology, Pulmonology/Respiratory
View More
Evolving Treatment Strategies in the Management of Pulmonary Arterial Hypertension: Key Insights for the Pharmacist, featuring a Patient Perspective
1.5 Credits / Pulmonology/Respiratory
View More
Advances in EGFR Exon 20 Insertion-Positive Non–Small Cell Lung Cancer: A Focus on Specialty Pharmacy Interventions
1.5 Credits / Oncology, Pulmonology/Respiratory
View More
Advances and Best Practices for Managed Care Pharmacists and the Treatment of Patients with Alpha-1 Antitrypsin Deficiency
1.0 Credit / Pulmonology/Respiratory
View More
COPD Is an Independent Risk Factor of Colorectal, Liver, Other Cancers
June 19th 2020Regardless of smoking status, chronic obstructive pulmonary disease (COPD) is an independent risk factor for developing lung, colorectal, liver and other cancers in the Korean population, according to a study published in BMC Pulmonary Medicine.
Read More
Lung Development May Explain Who Is at Higher Risk for COPD
June 11th 2020Up to 30% of cases of dysanapsis, having a small airway-to-lung ratio, occur in people who have never smoked, while not having the condition could explain why some heavy smokers never develop chronic obstructive pulmonary disease (COPD).
Read More
Study Details Characteristics of Patients with COPD, Asthma
May 30th 2020Danish investigators reviewed data of individuals prescribed inhaled corticosteroids (ICS) for chronic obstructive pulmonary disease (COPD) to compare characteristics of patients who have COPD alone with those who have COPD and concomitant asthma.
Read More
Early Detection Programs May Help Offset Costs of COPD Exacerbations, Studies Find
May 21st 2020Exacerbations of patients with chronic obstructive pulmonary disorder (COPD) can be costly if they are frequent, and early detection programs for COPD may help offset these costs, according to research from 2 studies presented at the 2020 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) virtual conference.
Read More
Pulmonary Rehabilitation for COPD Linked to Lower Risk of Death in FFS Medicare
May 12th 2020Although pulmonary rehabilitation for chronic obstructive pulmonary disease (COPD) is linked to better survival, a large study of fee-for-service (FFS) Medicare patients show it is underused, with less than 2% of those studied taking part in a 3-month program.
Read More
COPD Exacerbation Costs in the IMPACT Study: A Within-Trial Analysis
Treatment with fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) compared with FF/VI or UMEC/VI reduced exacerbation-related costs associated with chronic obstructive pulmonary disease (COPD) in the US healthcare system.
Read More
Analyzing Changes in Frailty Among Patients With COPD
April 11th 2020Over a 2-year study period, some patients with chronic obstructive pulmonary disease (COPD) were able to reverse or improve their frailty status, investigators found. The condition is present in close to one-third of patients with COPD.
Read More
Patients With COPD and No Smoking History Face Greater Risk of Lung Cancer, Study Says
April 3rd 2020A large-scale study reports that patients with chronic obstructive pulmonary disease (COPD)—even if they never smoked—have a 2.6 times greater incidence of developing lung cancer compared with those who had neither COPD or a history of smoking.
Read More
Initiation of Triple Therapy Maintenance Treatment Among Patients With COPD
Claims data analysis showed that 60% of patients with chronic obstructive pulmonary disease (COPD) receiving triple therapy had no evidence of exacerbation or only 1 exacerbation not resulting in hospitalization.
Read More
Practical Guidance to Improving COPD Management
March 26th 2020Thomas C. Corbridge, MD, FCCP, is a GSK medical expert and an emeritus physician and adjunct professor of medicine at Northwestern University, Feinberg School of Medicine in Chicago, Illinois. Dr. Corbridge received his medical degree from the University of Chicago Pritzker School of Medicine and has been in practice for over 30 years. Dr. Corbridge specializes in pulmonary and critical care medicine and is experienced in asthma, chronic obstructive pulmonary disease and general pulmonology.
Read More
BODE Index, Comorbidities Valuable for Predicting COPD Healthcare Resource Utilization
March 21st 2020Chronic obstructive pulmonary disease (COPD) may incur huge medical expenses, resulting in a heavy socioeconomic burden. A recent study sought to predict the level of healthcare utilization resources.
Read More
What We're Reading: Amazon Shipments; New COPD Treatment; High-Profile Mergers on Hold
March 18th 2020Amazon has decided to suspend nonessential item shipments; study results show patients with chronic obstructive pulmonary disease (COPD) benefited from a fluticasone furoate/umeclidinium/vilanterol combination inhaler; disruptions from the coronavirus now extend to proposed mergers among industry giants.
Read More
Lung Volume Reduction Coil Treatment Enables Recovery in Severe COPD Cases
March 11th 2020In 11 patients with severe cases of COPD and hypercapnic respiratory failure, lung volume reduction coil treatment was associated with significant decreases in carbon dioxide levels and improvement in quality-of-life and respiratory function tests, according to study findings.
Read More
COPD Closely Linked to Pollution, Outpatient Hospital Visits in Urban Area
February 29th 2020Researchers recently examined 18 diseases represented by outpatient visits to a hospital in Taiwan to determine patterns of the effect of air pollution on different organs and found evidence that concurrent occurrences of diseases show that the immune system tries to create protective defenses.
Read More
Statins Significantly Reduce Risk of Hospitalized Exacerbations in Patients With COPD
February 17th 2020Statin use was linked with a significant reduction in the risk of hospitalized exacerbations after an initial hospitalized exacerbation among patients with chronic obstructive pulmonary disease (COPD), including specified frequent exacerbators, according to study findings.
Read More
Care Coordination for Veterans With COPD: A Positive Deviance Study
Improving relational coordination and reducing structural barriers to collaboration may enhance quality of care for chronic obstructive pulmonary disease (COPD) and other chronic conditions.
Read More
In-Home Device Associated With Lower Mortality Risk, Less Need for Intubation in Patients With COPD
February 11th 2020In-home noninvasive positive pressure ventilation via bilevel positive airway pressure devices exhibited lower risk of mortality, fewer patients with all-cause hospital admission, and less need for intubation, but had no significant difference in quality-of-life for patients with chronic obstructive pulmonary disease (COPD) and hypercapnia, according to study findings.
Read More